Description
How It Works
Order Your Test
Once you have placed your order, your test kit will be delivered within days and in discreet packaging.
Activate & Collect Sample
After online activation of your test kit, you can collect your sample within a few minutes and mail it back to us in the pre-paid envelope.
View Results
A certified laboratory will review your sample and your test results will be available within a matter of days.
Reviews
Introduction
When you become infected with the COVID-19 virus, your body defends itself – as with other viral infections – and your immune system is activated to defend itself against the virus. After more than a week, the body usually produces acute antibodies (IgA and IgM) that fight directly against the virus. After an average of 10 to 14 days it will produce memory antibodies (IgG). While IgA and IgM will disappear over time, IgG will stay in the body longer and ensures that the immune response after (re) exposure to the same virus will be much faster and more effective than the first time. This means that our immune system can respond immediately and provides protection against the virus so that it cannot spread further. Antibodies are made in the days to weeks after infection with the virus. The strength of the antibody response depends on several factors, including age, disease severity, and certain medications or infections that may suppress the immune system. It can take 2 to 3 weeks for your body to produce the antibodies in sufficient quantities to detect them. During vaccination, the immune system is trained to optimize the immune response. The formation of IgG antibodies makes you (possibly) immune to another attack from the same virus. However, it is not yet clear how long protection will last. With this test, we can demonstrate whether and to what extent IgG antibodies are produced in your body after COVID-19 vaccination.
¹ Data refers to patients with infections. The first available data shows very robust antibody responses after vaccination which is why even better sensitivities can be expected after vaccination.
About the Test
The Anti-SARS-CoV-2 QuantiVac ELISA test is the latest development by EUROIMMUN for the quantitative detection of IgG antibodies against the coronavirus (SARS-CoV-2) in human serum and plasma. Using a blood sample, the test can detect antibodies against the new coronavirus that causes COVID-19, which would indicate whether a person has been exposed to the virus through vaccination and may have developed immunity to the virus. The high specificity of the test is critical to reliably determine whether a person has been exposed to the virus and whether the patient has developed antibodies.
The EUROIMMUN serological test measures the number of IgG antibodies in the blood. This quantitative assay uses a recombinant S1 subunit of the SARS-CoV-2 spike protein, allowing for quantitative detection of IgG antibodies. The production of IgG antibodies specifically is the focus for the various vaccine developers such as BioNtech / Pfizer, AstraZeneca and Moderna, as well as discussions about possible immunity in previously infected individuals. Using this new ELISA assay, EUROIMMUN provides a product to support a careful evaluation of an important antibody subgroup, enabling standard curve-based quantification of the anti-S1 IgG antibody concentration.
It is important to note that it can take 2 to 3 weeks for your body to produce the correct antibodies in sufficient quantities to detect them. The test is reliable for the detection of IgG antibodies when taken 14 days after receiving the second dose of the COVID-19 vaccine, optimally after 14 – 21 days.
The test process
Homed-IQ uses a Dry Blood Spot finger prick test delivered to your home. You prick yourself using a disposable lancet and deposit some drops of blood onto the paper blood collection card provided. After collecting the sample, send the materials to one of our certified partner laboratories by using the prepaid return envelope. Once the test results are available, they will be reviewed by a doctor and shared with you. All our tests are CE certified laboratory tests and are absolutely not ‘quick tests’!
About your test results
We closely follow guidelines set by the WHO to interpret the titres according to updated WHO standards. This means we share results in BAU (=binding antibody units).
- An antibody titre of <19.2 BAU/ml means that no antibodies against the coronavirus have been found in your blood.
- An antibody titre between ≥19.2 to <26.4 BAU/ml indicates a low amount of antibodies are present in your blood, yielding an unclear result.
- An antibody titre ≥ 26.4 BAU/ml means that your body has produced antibodies against the coronavirus. The higher the value, the higher the number of antibodies.
About the Test
Introduction
When you become infected with the COVID-19 virus, your body defends itself – as with other viral infections – and your immune system is activated to defend itself against the virus. After more than a week, the body usually produces acute antibodies (IgA and IgM) that fight directly against the virus. After an average of 10 to 14 days it will produce memory antibodies (IgG). While IgA and IgM will disappear over time, IgG will stay in the body longer and ensures that the immune response after (re) exposure to the same virus will be much faster and more effective than the first time. This means that our immune system can respond immediately and provides protection against the virus so that it cannot spread further. Antibodies are made in the days to weeks after infection with the virus. The strength of the antibody response depends on several factors, including age, disease severity, and certain medications or infections that may suppress the immune system. It can take 2 to 3 weeks for your body to produce the antibodies in sufficient quantities to detect them. During vaccination, the immune system is trained to optimize the immune response. The formation of IgG antibodies makes you (possibly) immune to another attack from the same virus. However, it is not yet clear how long protection will last. With this test, we can demonstrate whether and to what extent IgG antibodies are produced in your body after vaccination.
¹ Data refers to patients with infections. The first available data shows very robust antibody responses after vaccination which is why even better sensitivities can be expected after vaccination.
About the Test
The Anti-SARS-CoV-2 QuantiVac ELISA test is the latest development by EUROIMMUN for the quantitative detection of IgG antibodies against the coronavirus (SARS-CoV-2) in human serum and plasma. Using a blood sample, the test can detect antibodies against the new coronavirus that causes COVID-19, which would indicate whether a person has been exposed to the virus through vaccination and may have developed immunity to the virus. The high specificity of the test is critical to reliably determine whether a person has been exposed to the virus and whether the patient has developed antibodies.
The EUROIMMUN serological test measures the number of IgG antibodies in the blood. This quantitative assay uses a recombinant S1 subunit of the SARS-CoV-2 spike protein, allowing for quantitative detection of IgG antibodies. The production of IgG antibodies specifically is the focus for the various vaccine developers such as BioNtech / Pfizer, AstraZeneca and Moderna, as well as discussions about possible immunity in previously infected individuals. Using this new ELISA assay, EUROIMMUN provides a product to support a careful evaluation of an important antibody subgroup, enabling standard curve-based quantification of the anti-S1 IgG antibody concentration.
It is important to note that it can take 2 to 3 weeks for your body to produce the correct antibodies in sufficient quantities to detect them. The test is reliable for the detection of IgG antibodies when taken 14 days after receiving the second dose of the COVID-19 vaccine, optimally after 14 – 21 days.
The test process
Homed-IQ uses a Dry Blood Spot finger prick test delivered to your home. You prick yourself using a disposable lancet and deposit some drops of blood onto the paper blood collection card provided. After collecting the sample, send the materials to one of our certified partner laboratories by using the prepaid return envelope. Once the test results are available, they will be reviewed by a doctor and shared with you. All our tests are CE certified laboratory tests and are absolutely not ‘quick tests’!
Results
About your test results
We closely follow guidelines set by the WHO to interpret the titres according to updated WHO standards. This means we share results in BAU (=binding antibody units).
- An antibody titre of <19.2 BAU/ml means that no antibodies against the coronavirus have been found in your blood.
- An antibody titre between ≥19.2 to <26.4 BAU/ml indicates a low amount of antibodies are present in your blood, yielding an unclear result.
- An antibody titre ≥ 26.4 BAU/ml means that your body has produced antibodies against the coronavirus. The higher the value, the higher the number of antibodies.
Test Instructions
Frequently Asked Questions
COVID-19 is caused by the coronavirus: SARS-CoV-2. The disease can cause respiratory complaints and fever and can be similar to a cold (with symptoms such as chills, runny nose, sneezing and a sore throat). The disease can cause pneumonia and in severe cases, can lead to breathing problems with some people dying from the disease. Other common symptoms include cough, fatigue, generalized pain, muscle pain, dizziness, headache, diarrhoea, vomiting, and conjunctivitis. The virus was discovered in Wuhan, China, in early 2019 and has since spread worldwide. The coronavirus has caused a global pandemic and has been declared a public health emergency.
COVID-19 spreads easily from person to person through coughing and sneezing. For example, when an infected person coughs, sneezes, or exhales, tiny droplets of the virus are deposited into the air. Other people can become infected by inhaling these droplets or by touching their eyes, nose or mouth.
The incubation period is the number of days between the time you become infected and the time you develop symptoms. This is between 2 and 14 days for SARS-CoV-2, with symptoms usually appearing after 5 to 6 days.
Most people have mild symptoms. People with an increased risk of developing serious complaints are people over 70 years old (especially frail elderly people who need personal care) and adults (> 18 years) with: severe chronic abnormalities and functional disorders of the airways and lungs (asthma / COPD ), chronic heart disease, diabetes mellitus (poorly controlled DM or with secondary complications), severe kidney disease, adults with reduced resistance to infections: taking medication for autoimmune diseases, after organ or stem cell transplantation, haematological conditions, patients during and within 3 months after chemotherapy and/or radiation for cancer, HIV (untreated HIV or with low CD4 count (<200 / mm3)), mild to severe liver disease and adults with morbid obesity (BMI> 40).
Most countries, including the European Union, have already started to vaccinate. Most nationwide vaccination programs have started early 2021.
We recommend this test to people who want to know if they have been exposed to the coronavirus or have already been vaccinated and want to know if they have actually developed antibodies to protect them against future COVID-19 infections.
- People under 18 years old
- People who are currently experiencing severe symptoms of the coronavirus. In that case, we recommend that you seek immediate medical attention.
- Anyone with complaints of COVID-19 arising less than 14 days ago
- Anyone previously exposed to the virus and vaccinated less than 14 days ago
Homed-IQ uses a lab test that will be delivered to your home. Once you have taken the test for yourself, send the test material to the laboratory where the blood sample will be analyzed. Your test result will then be assessed by our doctor before the result will be returned to you. All our products are CE certified laboratory tests and not ‘quick tests’.
